SCA Pharma is a leading FDA 503B outsourcing facility delivering the highest quality sterile admixtures and pre-filled syringes to hospitals and health systems nationwide. Known for its unwavering quality and high-touch customer service, SCA Pharma prides itself on being the most customer- and patient-focused 503B in the industry. The company is headquartered in Little Rock, AR, with a sister facility in Windsor, CT, both of which meet or exceed FDA cGMP manufacturing guidelines. SCA Pharma employs over 500 people across its facilities and a team of sales representatives nationwide.
Founded in 2011, SCA Pharma has established itself as a trusted partner in the healthcare industry, providing essential sterile compounding services. The company's commitment to quality and customer service has made it a preferred choice for hospitals and health systems across the country.
With more than 90,000 square feet of sterile compounding laboratory and manufacturing space in Windsor, CT, and a 17,000 square foot facility in Little Rock, AR, SCA Pharma has the capacity to meet the diverse needs of its clients. The company's extensive experience and expertise in sterile compounding make it a valuable resource for healthcare providers seeking reliable and high-quality pharmaceutical solutions.
Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.
| Ownership Private Company |
B2B professionals would contact SCA Pharma for its unparalleled quality and customer-focused approach in sterile compounding services. The company's extensive facilities and adherence to FDA cGMP guidelines make it a reliable partner for healthcare providers seeking high-quality pharmaceutical solutions.
Sales teams selling pharmaceutical services, recruiters seeking roles in sterile compounding, and partners offering sterile compounding capabilities should reach out to SCA Pharma.
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Connect with SCA Pharma